HK2 and non-small cell lung carcinoma: Additionally, silencing exosomal circ_PIP5K1A suppresses NSCLC progression and enhances cisplatin sensitivity through modulation of the miR-101-ABCC1 axis (Shao et al., 2021), whereas knockdown of exosomal circ_0008928 inhibits NSCLC progression and augments cisplatin sensitivity via regulation of the miR-488-HK2 axis (Shi Q. et al., 2023).